Preparing for future pandemics
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
Find out more
Latest News
Latest News
Rethinking regulation to face future pandemic threats
Regulatory preparedness underscores the 100 Days Mission. Find out how.
Preparedness in practice: Rwanda’s record-breaking Marburg response
Practicing 100 Days Mission preparedness in Rwanda and beyond
Responsibly unleashing artificial intelligence in pandemic preparedness
Meeting innovation with responsibility
CEPI signs new collaborative agreement with US Dept of Defense to expand protection against disease outbreaks
Agreement will enable organisations to collaborate on projects that expand global defences against disease outbreaks.
Public health expert Dr. Kesete Admasu joins CEPI Board
He brings over twenty years of experience working across public health, infectious disease initiatives and philanthropic investment.
.webp){kind=logo}
CEPI statement on the adoption of the Pandemic Agreement
CEPI welcomes the adoption of the Pandemic Agreement
Leading health partners join coalition set up to combat deadly Lassa fever
The organisations will work with CEPI and WAHO to advance the fight against the infectious disease.
Faster outbreak survivor sample collection can help stop pandemics in their tracks
CEPI and PATH are teaming up to create the Biospecimen Sourcing Initiative.
CEPI and the Norwegian Institute of Public Health strengthen pandemic preparedness partnership
CEPI and the Norwegian Institute of Public Health signs MoU to strengthen their pandemic preparedness partnership.
Boosting access to mRNA vaccines through innovative mRNA delivery platform
Novel targeted delivery platform could help to increase the stability of mRNA-based vaccines
Latest News
We want to create a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.
Our approach
Research and development
CEPI is leading a broad range of ambitious programmes that aim to substantially reduce global epidemic and pandemic risk.
Calls for Proposals
Innovators worldwide are invited to apply to our scientific programmes to advance the development and manufacture of vaccines and tools against epidemic and pandemic threats.
Manufacturing and supply chain
CEPI is bolstering global manufacturing capacity in underserved regions and harnessing innovative technologies to improve the speed, scale and access of vaccine manufacturing in response to epidemic and pandemic threats.
The Viral Most Wanted
Join CEPI’s disease detectives as they investigate the viral families that have threatened human life for centuries.
$12.5 trillion
IMF’s estimate cost of the COVID-19 pandemic to the global economy through 2024
60+
Number of CEPI-supported vaccine candidates or platform technologies.
$2.8 billion
The minimum average cost to progress one vaccine each against 11 WHO priority infectious diseases
Emerging infectious diseases affect us all. They do not respect borders.
A commitment to equitable access informs every aspect of our work. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity.
CEPI take a systems approach to equitable access, seeking to enable equitable access within a broad ecosystem of national and international public and private sector partners and networks.
We work towards this goal by enabling equitable access directly through financial investments and partnerships, and indirectly through advocacy and policy contributions to the evolving ecosystem.
Where to go next
